| CVD | cardiovascular disease |
| Th cell | T helper cell |
| IL | interleukin |
| TNF | tumour necrosis factor |
| IFN-γ | interferon-gamma |
| MACE | major cardiac event |
| MI | myocardial infarct |
| HR | hazard ratio |
| CI | confidence interval |
| IMT | intima media thickness |
| cIMT | carotid intima media thickness |
| fIMT | femoral intima media thickness |
| bIMT | brachial intima media thickness |
| ICAM-1 | intercellular adhesion molecule 1 |
| ApoE | apolipoprotein E |
| ROR γt | retinoic acid-related orphan receptor γt |
| PKCß/ERK1/2/NF-κB | protein kinase C beta/extracellular signal-regulated kinase 1/2/nuclear factor kappa-light-chain-enhancer of activated B cells |
| VCAM-1 | vascular cell adhesion molecule 1 |
| QoL | quality of life |
| PASI | psoriasis area severity index |
| DLQI | dermatology life quality index |
| EQ VAS | euroQol visual analogue scale |
| IQR | interquartile range |
| MTX | methotrexate |
| BMI | body mass index |
| AHA/ACC/TOS | American Heart Association/ American College of Cardiology/ The Obesity Society |
| FMD | flow mediated dilatation |
| CARIMA | Evaluation of Cardiovascular Risk Markers in Psoriasis Patients Treated With Secukinumab |
| FAI | fat attenuation index |
| TGF-β | transforming growth factor–β |
| SMAD7 | mothers against decapentaplegic homolog 7 |